Carcinoembryonic Antigen

From Taranaki Lab Manual
Revision as of 20:09, 14 September 2026 by Clair Crossley (Crossley1) (talk | contribs) (Mark as reviewed)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tests:Carcinoembryonic Antigen
Jump to navigation Jump to search


Overview

Department Biochemistry
Test Code TCEA
Synonyms CEA 
Availability Monday - Friday

Contact the lab if urgent testing is required

Turnaround Time 2 hours – 3 days
Stability – Add test 24 hours 

Specimen Requirements

Specimen Serum
Preferred Yellow-Top or Red-Top tube
Acceptable
Unacceptable Plasma
Specimen Transportation
Paediatric Requirements 0.5 mL blood in Red-Top tube

Aliquot Requirements

Sample Serum
Preferred Volume 0.5 mL
Minimum Volume 100 µL 
Aliquot Transportation

Clinical Information

Reference Intervals 0.0 - 5.0 µg/L 
Test Method Abbott Alinity CI analyser, CMIA method. 
Advanced Notice Not required  
Patient Preparation Not required  

Comments

CEA is a marker for colorectal, gastrointestinal, lung and breast carcinomas. 

CEA levels are not an absolute test for evidence of malignancy and must be used in conjunction with the clinical evaluation of the patient and other diagnostic evidence.

Healthy non-smokers have CEA levels less than 3.0 µg/mL, while 6% of otherwise healthy smokers have CEA levels up to 5.0 µg/mL. 

CEA is not suitable as a screening test for the primary diagnosis of tumours.

For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.

Owner Clair Crossley (Crossley1)
Last reviewed 14.09.2026
Next review 14.09.2027 (OK)